NASDAQ · Biotechnology
Capricor Therapeutics Inc (CAPR)
$7.59
+0.80%
49
In band
Moving averages
SMA 200$20.14-62.31%
Company profile
Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapies for the treatment and prevention of a broad spectrum of diseases. The company is headquartered in Beverly Hills, California.
SectorHealthcare
IndustryBiotechnology
Market cap$652.32M
P/E ratioNone
EPS$-2.65
Beta0.767
Dividend yield0.00%
52-week high$40.37
52-week low$2.96
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 40
GERN
Geron Corp
RSI 44
CADL
Candel Therapeutics Inc
RSI 27
ARDX
Ardelyx Inc
RSI 46
ALT
Altimmune Inc
RSI 23
EDIT
Editas Medicine Inc
RSI 30
RSI alerts for CAPR
An email when CAPR closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 5:23 AM EST